Evidence map›Paper›PMID 16319366›Full record

ArticleTobacco control2005

Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death.

R Hubbard, S Lewis, C Smith, C Godfrey, L Smeeth, P Farrington, J Britton

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Tobacco control, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Smoking-cessation pharmacotherapy for patients with stroke and TIA: Systematic review.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2020
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Expression Changes of Apoptotic Genes in Tissues from Mice Exposed to NicotineAsian Pacific journal of cancer prevention : APJCP · 2017
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

R HubbardDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, UK. Richard.Hubbard@Nottingham.ac.uk
S Lewis
C Smith
C Godfrey
L Smeeth
P Farrington
J Britton
University of Nottingham · GBLondon School of Hygiene & Tropical Medicine · GBThe Open University · GBUniversity of York · GB

Funding

Medical Research Council G108/492Wellcome Trust
6 · The paper itself

Abstract

objectiveTo determine whether nicotine replacement therapy (NRT) is associated with an increased risk of acute myocardial infarction, acute stroke, or death.

designSelf control case series analysis of data from The Health Improvement Network (THIN) to estimate the relative incidence of myocardial infarction and stroke in four 14 day periods before and after the first prescription for NRT.

settingTHIN is a computerised general practice database. SUBJECTS: Patients contributing data to THIN.

interventionsObservational study of NRT. MAIN OUTCOMES: Acute myocardial infarction, acute stroke, and death.

results33,247 individuals had been prescribed NRT, of whom 861 had had a myocardial infarction and 506 a stroke. There was a progressive increase in the incidence of first myocardial infarction in the 56 days leading up to the first NRT prescription (overall incidence ratio 5.55, 95% confidence interval (CI) 4.42 to 6.98), but the incidence fell after this time and was not increased in the 56 days after starting NRT (incidence ratio 1.27, 95% CI 0.82 to 1.97). The results were similar for second myocardial infarction and stroke, and for subgroups of people with pre-existing angina and hypertension. There were 960 deaths in our cohort during a mean follow up period of 2.6 years after starting NRT, with no evidence of an increased mortality in the 56 days after the NRT prescription (incidence ratio 0.86, 95% CI 0.60 to 1.23).

conclusionsThe use of NRT is not associated with any increase in the risk of myocardial infarction, stroke, or death.

Indexed as

AdultAge FactorsDatabases as TopicFamily PracticeFemaleHumansIncidenceMaleMiddle AgedMortalityMyocardial InfarctionNicotineNicotinic AgonistsSex FactorsSmoking CessationStrokeNicotineNicotinic Agonists

Identifiers

PMID16319366
PMCPMC1748112
OpenAlexW2158521667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.